NEW YORK, NY / ACCESSWIRE / April 4, 2024 / Bronstein, Gewirtz & Grossman, LLC, is investigating potential claims on behalf of purchasers of Doximity, Inc. ("Doximity" or "the Company") (NYSE:DOCS). Investors who purchased Doximity securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/DOCS.
Investigation Details:
On April 1, 2024, during market hours, Jehosaphat Research released a report on Doximity. In this report, Jehosaphat stated, among other things, that "[w]e believe this healthcare advertising business is coming under pressure due to a variety of fundamental issues, which we've investigated via forensic accounting analysis, interviews with former employees and digital marketing agencies, [. . .] and other means." Further, Jehosaphat stated that it believed Doximity's underlying sales had been declining, "but that this decline has been masked through accelerated revenue recognition."
On this news, the price of Doximity stock fell in intraday trading on April 1, 2024.
What's Next?
If you are aware of any facts relating to this investigation or purchased Doximity securities, you can assist this investigation by visiting the firm's site: bgandg.com/DOCS. You can also contact Peretz Bronstein or his law clerk and client relations manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 332-239-2660.
There is No Cost to You
We represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman:
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Nathanson
332-239-2660 | [email protected]
SOURCE: Bronstein, Gewirtz & Grossman, LLC